Showing 1 - 10 of 44
AFP, Published on 07/08/2025
» WASHINGTON - From mouth taping to rope-assisted neck swinging, a viral social media trend is promoting extreme bedtime routines that claim to deliver perfect sleep -- despite scant medical evidence and potential safety risks.
AFP, Published on 12/12/2023
» WASHINGTON - A new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.
AFP, Published on 14/11/2023
» PARIS - "There's a lot of jealousy in football," said Sheikh Issa, holding up a piece of bark and a bottle of a yellowish potion.
AFP, Published on 22/08/2023
» WASHINGTON - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.
AFP, Published on 05/06/2023
» WASHINGTON - A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.
AFP, Published on 07/01/2023
» WASHINGTON - The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in the early stages of Alzheimer's disease.
AFP, Published on 23/05/2022
» WASHINGTON: The Pfizer/BioNTech Covid vaccine is safe and effective for children aged six months to under five years when given in three doses, the companies said in a statement Monday.
AFP, Published on 15/12/2021
» WASHINGTON: Pfizer said Tuesday that clinical trials confirmed its Covid pill -- a new type of treatment that should withstand the mutations seen with the Omicron variant -- drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.
AFP, Published on 14/12/2021
» WASHINGTON - Pfizer said Tuesday that clinical trials confirmed its Covid pill, a new type of antiviral treatment that should withstand the mutations seen with Omicron, drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.